Jennerex
Transgene acquires rights to cancer vaccine
September 10, 2010Research and Development JX-594, Jennerex, Transgene, cancer vaccine
French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
